Narp Regulates Long-Term Aversive Effects of Morphine Withdrawal

Behavioral Neuroscience

Volumn 122, Issue 4, 2008, Pages 760-768

  Reti, Irving M ^a,b   Crombag, Hans S ^c   Takamiya, Kogo ^b   Sutton, Jeffrey M ^c   Guo, Ning ^c   Dinenna, Megan L ^c   Huganir, Richard L ^b   Holland, Peter C ^b,c   Baraban, Jay M ^a,b  

^a Department of Psychiatry and Behavioral Sciences ^*

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

AMPA; amygdala; immediate early gene; Naltrexone; place aversion

Indexed keywords

AMPA RECEPTOR; GENE PRODUCT; MORPHINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GENE CONTROL; GENE DELETION; IMMEDIATE EARLY GENE; KNOCKOUT MOUSE; LIMBIC CORTEX; MALE; MOTIVATION; MOUSE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; REINFORCEMENT; WILD TYPE; WITHDRAWAL SYNDROME;

AMYGDALA; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; C-REACTIVE PROTEIN; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NERVE TISSUE PROTEINS; RETENTION (PSYCHOLOGY); SEPTAL NUCLEI; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 50849097578     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0012514     Document Type: Article

References (51)

1. Bjartmar L., Huberman A.D., Ullian E.M., Rentería R.C., Liu X., Xu W., et al. Neuronal pentraxins mediate synaptic refinement in the developing visual system. Journal of Neuroscience 26 (2006) 6269-6281
2. Cho R.W., Park J.M., Wolff S.B., Xu D., Hopf C., Kim J.A., et al. mGluR1/5-dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE. Neuron 57 (2008) 858-871
3. Crombag H.S., Badiani A., Maren S., and Robinson T.E. The role of contextual versus discrete drug-associated cues in promoting the induction of psychomotor sensitization to intravenous amphetamine. Behavioural Brain Research 116 (2000) 1-22
4. Cunningham C.L. Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice. Psychopharmacology 120 (1995) 28-41
5. Cunningham C.L., Dickinson S.D., Grahame N.J., Okorn D.M., and McMullin C.S. Genetic differences in cocaine-induced conditioned place preference in mice depend on conditioning trial duration. Psychopharmacology (Berlin) 146 (1999) 73-80
6. Cunningham C.L., Gremel C.M., and Groblewski P.A. Drug-induced conditioned place preference and aversion in mice. Nature Protocols 1 (2006) 1662-1670
7. Cunningham C.L., Niehus D.R., Malott D.H., and Prather L.K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology 107 (1992) 385-393
8. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 (2000) 430-434
9. Frenois F., Stinus L., Di Blasi F., Cador M., and Le Moine C. A specific limbic circuit underlies opiate withdrawal memories. Journal of Neuroscience 25 (2005) 1366-1374
10. Gardner S.M., Takamiya K., Xia J., Suh J.G., Johnson R., Yu S., et al. Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF. Neuron 45 (2005) 903-915
11. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. Journal of Neuroscience 23 (2003) 3106-3111
12. Goldberg S.R., Woods J.H., and Schuster C.R. Morphine: Conditioned increases in self-administration in rhesus monkeys. Science 166 (1969) 1306-1307
13. Heimer L., Alheid G.F., de Olmos J.S., Groenewegen H.J., Haber S.N., Harlan R.E., et al. The accumbens: Beyond the core-shell dichotomy. Journal of Neuropsychiatry and Clinical Neurosciences 9 (1997) 354-381
14. Heinrichs S.C., Menzaghi F., Schulteis G., Koob G.F., and Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behavioural Pharmacology 6 (1995) 74-80
15. Hellemans K.G., Everitt B.J., and Lee J.L. Disrupting reconsolidation of conditioned withdrawal memories in the basolateral amygdala reduces suppression of heroin seeking in rats. Journal of Neuroscience 26 (2006) 12694-12699
16. Hutcheson D.M., Everitt B.J., Robbins T.W., and Dickinson A. The role of withdrawal in heroin addiction: Enhances reward or promotes avoidance?. Nature Neuroscience 4 (2001) 943-947
17. Johnson A.W., Crombag H.S., Takamiya K., Baraban J.M., Holland P.C., Huganir R.L., et al. Selective role of Narp in processing sensory-specific incentive learning. Journal of Neuroscience 4 (2007) 13430-13435
18. Kenny P.J., Chen S.A., Kitamura O., Markou A., and Koob G.F. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. Journal of Neuroscience 26 (2006) 5894-5900
19. Kest B., Palmese C.A., Hopkins E., Adler M., and Juni A. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacology, Biochemistry and Behavior 70 (2001) 149-156
20. Khantzian E.J. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry 142 (1985) 1259-1264
21. Kim J.H., Lee H.K., Takamiya K., and Huganir R.L. The role of synaptic GTPase activating protein in neuronal development and synaptic plasticity. Journal of Neuroscience 23 (2003) 1119-1124
22. Kirkpatrick L.L., Matzuk M.M., Dodds D.C., and Perin M.S. Biochemical interactions of the neuronal pentraxins: Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2. Journal of Biological Chemistry 275 (2000) 17786-17792
23. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Annals of the New York Academy of Sciences 877 (1999) 445-460
24. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature Neuroscience 8 (2005) 1442-1444
25. Lu W., Marinelli M., Xu D., Worley P.F., and Wolf M.E. Amphetamine and cocaine do not increase Narp expression in rat ventral tegmental area, nucleus accumbens or prefrontal cortex, but Narp may contribute to individual differences in responding to a novel environment. European Journal of Neuroscience 15 (2002) 2027-2036
26. Maldonado R., and Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Research 605 (1993) 128-138
27. Maldonado R., Stinus L., Gold L.H., and Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. Journal of Pharmacology and Experimental Therapeutics 261 (1992) 669-677
28. Milad M.R., and Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420 (2002) 70-74
29. Morgan M.A., and LeDoux J.E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behavioral Neuroscience 109 (1995) 681-688
30. Morgan M.A., Romanski L.M., and LeDoux J.E. Extinction of emotional learning: Contribution of medial prefrontal cortex. Neuroscience Letters 163 (1993) 109-113
31. O'Brien C.P., Testa T., O'Brien T.J., Brady J.P., and Wells B. Conditioned narcotic withdrawal in humans. Science 195 (1977) 1000-1002
32. O'Brien R.J., Xu D., Petralia R.S., Steward O., Huganir R.L., and Worley P. Synaptic clustering of AMPA receptors by the extracellular immediate early gene product Narp. Neuron 23 (1999) 309-323
33. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates. 2nd ed. (2001), Academic Press, New York
34. Reti I.M., and Baraban J.M. Opiate withdrawal induces Narp in the extended amygdale. Neuropsychopharmacology 28 (2003) 1606-1613
35. Reti I.M., Minor L.B., and Baraban J.M. Selective expression of Narp in central vestibular pathways: Dependence on sensory input. European Journal of Neuroscience 16 (2002) 1949-1958
36. Reti I.M., Miskimon M., Dickson M., Petralia R.S., Takamiya K., Bland R., et al. Activity-dependent secretion of neuronal activity regulated pentraxin from vasopressin neurons into the systemic circulation. Neuroscience 151 (2008) 352-360
37. Reti I.M., Reddy R., Worley P.F., and Baraban J.M. Prominent Narp expression in projection pathways and terminal fields. Journal of Neurochemistry 82 (2002) 935-944
38. Reti I.M., Reddy R., Worley P.F., and Baraban J.M. Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons. Journal of Neurochemistry 82 (2002) 1561-1565
39. Sakoori K., and Murphy N.P. Maintenance of conditioned place preferences and aversion in C57BL6 mice: Effects of repeated and drug state testing. Behavioural Brain Research 160 (2005) 34-43 (Published electronically December 29, 2004)
40. Schulteis G., Ahmed S.H., Morse A.C., Koob G.F., and Everitt B.J. Conditioning and opiate withdrawal. Nature 405 (2000) 1013-1014
41. Shaw-Lutchman T.Z., Barrot M., Wallace T., Gilden L., Zachariou V., Impey S., et al. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. Journal of Neuroscience 22 (2002) 3663-3672
42. Sotres-Bayon F., Bush D.E., and LeDoux J.E. Emotional perseveration: An update on prefrontal-amygdala interactions in fear extinction. Learning & Memory 11 (2004) 525-535
43. Sotres-Bayon F., Cain C.K., and LeDoux J.E. Brain mechanisms of fear extinction: Historical perspectives on the contribution of prefrontal cortex. Biological Psychiatry 60 (2006) 329-336 (Erratum in Biological Psychiatry, 60, 666)
44. Stinus L., LeMoal M., and Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37 (1990) 767-773
45. Sutton M.A., Schmidt E.F., Choi K.H., Schad C.A., Whisler K., Simmons D., et al. Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421 (2003) 70-75
46. Tsui C.C., Copeland N.G., Gilbert D.J., Jenkins N.A., Barnes C., and Worley P. Narp, a novel member of the pentraxin family, promotes neurie outgrowth and is dynamically regulated by neuronal activity. Journal of Neuroscience 16 (1996) 2463-2478
47. Vezina P., and Stewart J. Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field. Psychopharmacology (Berlin) 91 (1987) 375-380
48. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., and Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Japanese Journal of Pharmacology 88 (2002) 399-406
49. Watanabe T., Yamamoto R., Maeda A., Nakagawa T., Minami M., and Satoh M. Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats. Brain Research 958 (2002) 423-428
50. Xu D., Hopf C., Reddy R., Cho R.W., Guo L., Lanahan A., et al. Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity. Neuron 39 (2003) 513-528
51. Zushida K., Sakurai M., Wada K., and Sekiguchi M. Facilitation of extinction learning for contextual fear memory by PEPA: A potentiator of AMPA receptors. Journal of Neuroscience 27 (2007) 158-166